The short version
6 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Atropine Sulfate
Atropine Sulfate · ATROPINE SULFATE .4 mg/mL · Solution · Intravenous · ProPharma Distribution
NDC 84549-0631-25 · 1 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for atropine sulfate (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- ProPharma DistributionUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $47.18 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215969
- TE code
- AP
- Approval date
- Jul 3, 2024
- Patents / exclusivity
- None on file
Shortage history
- In shortage now — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)Jan 1, 2012month 177 — 15× the typical 12-month other shortage
- In shortage now — Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)Jan 1, 2012month 177 — 15× the typical 12-month other shortage
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Atropine Sulfate (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alcon Laboratories, Inc. | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Americas Inc. | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ATROPINE SULFATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| ProPharma Distribution | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | ATROPINE SULFATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Atropine Sulfate — NDC 84549-0631-25," retrieved September 3, 2026, https://drugdashboards.com/drug/84549063125.
Free to cite with attribution — see how the data is put together.